Endostatin neoadjuvant gene therapy extends survival in an orthotopic metastatic mouse model of renal cell carcinoma

Biomedicine and Pharmacotherapy

Volumn 66, Issue 4, 2012, Pages 237-241

  Braga, Marina de Souza ^a,c   Chaves, Karen Barbosa ^a   Chammas, Roger ^b   Schor, Nestor ^a   Bellini, Maria Helena ^a,c  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c INSTITUTO DE PESQUISAS ENERGÉTICAS E NUCLEARES   (Brazil)

Author keywords

Endostatin; Gene therapy; Neoadjuvant therapy; Retroviral vector

Indexed keywords

ENDOSTATIN;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER GENE THERAPY; CANCER LOCALIZATION; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; KAPLAN MEIER METHOD; KIDNEY METASTASIS; LUNG METASTASIS; LUNG NODULE; MALE; MICROVASCULARIZATION; MOUSE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE;

ANIMALS; CARCINOMA, RENAL CELL; CELL PROLIFERATION; COMBINED MODALITY THERAPY; ENDOSTATINS; GENE THERAPY; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; NEOADJUVANT THERAPY; NEOPLASM METASTASIS; NEPHRECTOMY; NIH 3T3 CELLS; SURVIVAL RATE;

EID: 84862491317     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2011.11.002     Document Type: Article

References (19)

1. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108.
2. Veldt A.A.M., Haanen J.B., Eertwegh A.J.M., Boven E. Targeted therapy for renal cell cancer: current perspectives. Johns Hopkins Med 2010, 10:394-395.
3. Kapoor A., Lambe S., Whelan J.P. Laparoscopic right donor nephrectomy. BJU Int 2009, 103:998-1013.
4. Atkins M, Hidalgo M, Stadler W, et al. A randomized double-blind phase 2 study of intravenous CCI-779 administered weekly to patients with advanced renal cell carcinoma. Proc Am Soc Clin Oncol 2002;21(abstr 36).
5. Di Lorenzo G., Autorino R., Sternberg C.N. Metastatic renal cell carcinoma: recent advances in the targeted therapy era. Eur Urol 2009, 56:959-971.
6. Shuch B., Riggs S.B., Larochelle J.C., et al. Neoadjuvant targeted therapy and advanced kidney cancer: observations and implications for a new treatment paradigm. BJU Int 2008, 102:692-696.
7. Wood C.G., Margulis V. Neoadjuvant (presurgical) therapy for renal cell carcinoma: a new treatment paradigm for locally advanced and metastatic disease. Am Cancer Soc 2009, 115:2344-2360.
8. Kondo T., Hashimoto Y., Kobayashi H., et al. Template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract: Impact on patient survival. Int J Urol 2010, 17:848-854.
9. Ficarra V., Novara G. Kidney cancer: neoadjuvant targeted therapies in renal cell carcinoma. Nat Rev Urol 2010, 7:63-64.
10. Rocha F.G., Calvo F.B., Chaves K.C., et al. Endostatin- and interleukin-2-expressing retroviral bicistronic vector for gene therapy of metastatic renal cell carcinoma. J Gene Med 2011, 13:148-157.
11. Rocha F.G., Chaves K.C., Chammas R., et al. Endostatin gene therapy enhances the efficacy of IL-2 in suppressing metastatic renal cell carcinoma in mice. Cancer Immunol Immunother 2010, 59:1357-1365.
12. Coutinho E.L., Andrade L.N., Chammas R., et al. Anti-tumor effect of endostatin mediated by retroviral gene transfer in mice bearing renal cell carcinoma. FASEB J 2007, 21:3153-3161.
13. Yang L., Lin Z., Lin J., et al. Antitumor effect of endostatin overexpressed in C6 glioma cells is associated with the down-regulation of VEGF. Int J Oncol 2011, 38:465-471.
14. Lam J.S., Shvarts O., Leppert J.T., Figlin R.A., Belldegrun A.S. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy. J Urol 2005, 173:1853-1862.
15. Robert G., Gabbay G., Bram R., et al. Complete histologic remission after sunitinibneoadjuvant therapy in T3b renal cell carcinoma. Eur Urol 2009, 55:1477-1480.
16. Bellmunt J., Flodgren P., Roigas J., Oudard S. Optimal management of metastatic renal cell carcinoma: an algorithm for treatment. BJU Int 2009, 104:10-18.
17. Feldman A.L., Libutti S.K. Progress in antiangiogenic gene therapy of cancer. Am Cancer Soc 2000, 89:1181-1194.
18. Dhanabal M., Ramchandra R., Waterma M.J.F., et al. Endostatin induce endothelial cell apoptosis. J Biol Chem 1999, 274:1721-1726.
19. Folkman J. Fundamental concepts of the angiogenic process. Curr Mol Med 2003, 3:643-651.